David Marek
2020 - Myovant Sciences Ltd.
In 2020, David Marek earned a total compensation of $10.3M as Principal Executive Officer at Myovant Sciences Ltd..
Compensation breakdown
| Bonus | $1,000,000 |
|---|---|
| Non-Equity Incentive Plan | $116,000 |
| Option Awards | $4,383,438 |
| Salary | $150,544 |
| Stock Awards | $4,581,981 |
| Other | $44,554 |
| Total | $10,276,517 |
Marek received $4.6M in stock awards, accounting for 45% of the total pay in 2020.
Marek also received $1M in bonus, $116K in non-equity incentive plan, $4.4M in option awards, $150.5K in salary and $44.6K in other compensation.
Rankings
In 2020, David Marek's compensation ranked 802nd out of 13,090 executives tracked by ExecPay. In other words, Marek earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 802 out of 13,090 | 94th |
Division Manufacturing | 285 out of 5,620 | 95th |
Major group Chemicals And Allied Products | 91 out of 2,253 | 96th |
Industry group Drugs | 80 out of 1,953 | 96th |
Industry Pharmaceutical Preparations | 61 out of 1,458 | 96th |
Source: SEC filing on July 27, 2022.
Marek's colleagues
We found one more compensation record of an executive who worked with David Marek at Myovant Sciences Ltd. in 2020.
2020
Frank Karbe
Myovant Sciences Ltd.